PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
23-Nov-2022 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Announces Successful Listing of 2,054,796 Shares (news with additional features) Vivoryon Therapeutics N.V.
22-Nov-2022 ALTURiX CEYESTO® Granted Expanded UK Indication By the MHRA ALTURiX
22-Nov-2022 Vita 34 benefits from increasing normalization in its core business in the third quarter Vita 34 AG
22-Nov-2022 Achilles Therapeutics Announces Grant of US Patent on Immunotherapies Targeting Clonal Neoantigens Identified Using Proprietary Method Achilles Therapeutics
22-Nov-2022 iTeos to Present at the Piper Sandler 34th Annual Healthcare Conference iTeos Therapeutics, Inc
22-Nov-2022 Agios Pharmaceuticals Celebrates PYRUKYND® Launch Success with Almac Group Agios Pharmaceuticals
22-Nov-2022 Medios AG: Acquisition of Blisterzentrum Baden-Württemberg GmbH and expansions in the area of sterile manufacturing Medios AG
22-Nov-2022 Kinarus Receives USPTO Notice of Allowance for Lead Therapeutic Candidate KIN001 Kinarus Therapeutics Holding AG
22-Nov-2022 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Third Quarter 2022 Financial Results and Highlights Operational Progress (news with additional features) Vivoryon Therapeutics N.V.
22-Nov-2022 Kinarus Receives USPTO Notice of Allowance for Lead Therapeutic Candidate KIN001 Kinarus Therapeutics Holding AG
21-Nov-2022 Ellipses Pharma to present clinical updates at leading U.S. breast and blood cancer conferences Ellipses Pharma
21-Nov-2022 Nordic Nanovector comment on Proposed Merger with APIM Therapeutics Nordic Nanovector
21-Nov-2022 OKYO Pharma Announces U.S. IND Filing on OK-101 for the Treatment of Dry Eye Disease OKYO Pharma
21-Nov-2022 Marinomed Biotech AG reports increase in revenues for the first 9 months 2022 and significant business development progress Marinomed Biotech AG
21-Nov-2022 Xlife Sciences initiates a review of strategic options Xlife Sciences AG
21-Nov-2022 APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival Relief Therapeutics Holding SA
18-Nov-2022 Weekly Pharma & Life Science News Round-Up: 14th – 18th November PharmiWeb.Jobs
18-Nov-2022 European Commission approves Enjaymo® (sutimlimab) for treatment of hemolytic anemia in adult patients with cold agglutinin disease Sanofi
17-Nov-2022 BeiGene Receives European Commission Approval for BRUKINSA® (zanubrutinib) for the Treatment of Adults with Chronic Lymphocytic Leukemia (CLL) BeiGene
17-Nov-2022 PureTech to Present at Two Upcoming Investor Conferences PureTech